Table 1 Comparison of murine and human mast cells

From: Advances in mast cell biology: new understanding of heterogeneity and function

Feature

Murine mast cells

Human mast cells

References

General phenotype classification

MMC, CTMC

Based on granule proteoglycan expression

Relatively well correlated with tissue distribution

MCT, MCTC, MCC

Based on granule protease expression

23, 24, 27, 268, 269, 270

Proteoglycan

MMC: Chondroitind sulfate di-B, A, E

CTMC: Heparin, Chondroitin sulfate E

Heparin, Chondroitin sulfate A, E

26

Protease

Several tryptases and chymases with different specificities (e.g., mouse MMCs predominantly express MMCP-1 and -2, whereas mouse CTMCs predominantly express MMCP-3, -4, -5, -6, -7, and carboxypeptidase)

MCT: Tryptase

MCTC: Tryptase, chymase

MCC: Chymase

Three MC tryptases (α, β, and γ) and one chymase have been identified

26, 269, 270

Biogenic amine

MMC: Histamine (<1 pg per cell), Serotonin

CTMC: Histamine (≥15 pg per cell), Serotonin

Histamine, Serotonin

24, 26, 271, 272, 273

Major growth factors

IL-3, SCF

SCF

54, 57, 58, 59, 274

CD117 (SCFR)

+

IL-4, IL-10, and TGFβ1 inhibit CD117 expression

+

IL-4 inhibits CD117 expression

219, 222, 223, 232, 233

FcɛRI

+

IL-4, IL-10, and TGFβ1 inhibit FcɛRI expression

+

IL-4 enhances FcɛRI expression

218, 223, 224, 229, 230, 231

FcγR

FcγRIIb1, FcγRIIb2, FcγRIII: constitutively expressed in mouse BMMCs, RBL-2H3, and increased expression in mouse mature PMCs

FcγRI: IFNγ enhances FcγRI expression in PBMCs

FcγRII: PBMCs constitutively express FcγRIIa. SMCs constitutively express FcγRIIa but not FcγRIIb, whereas CBMCs constitutively express FcγRIIb but neither FcγRIIa nor FcγRIIc

136, 138, 275, 276, 277, 278, 279

MHC

MHC-I: constitutively expressed in mouse BMMCs

MHC-II: IFNγ and LPS enhance MHC-II expression in mouse BMMCs and spleen-derived MCs. IL-3 inhibits MHC-II expression in mouse BMMCs. IFNγ enhances MHC-II expression in rat MCs isolated from pleural cavity. IFNγ and IL-4 enhance MHC-II expression in mouse PCMCs

MHC-I: constitutively expressed in human skin, lung, liver and uterus MCs, and HMC-1

MHC-II: IFNγ and TNF enhance MHC-II expression in HMC-1

88, 89, 92, 93, 94, 95, 96, 97

Sex hormone receptor

ERα: constitutively expressed in mouse BMMCs, rat PMCs, and RBL-2H3

PR: constitutively expressed in mouse BMMCs and rat PMCs

ERα: constitutively expressed in human MCs in nasal polyps, abdominal aortic vessels (fertile women), HMC-1, and LAD2

PR: constitutively expressed in human MCs in nasal polyps and HMC-1

251, 252, 253, 254, 255, unpublished dataa

NOS

Mouse MCs: iNOS, eNOS

Rat MCs: nNOS, iNOS, eNOS

nNOS, iNOS, eNOS

237, unpublished dataa

  1. BMMC, bone marrow-derived mast cell; CBMC, human cord blood-derived mast cell; CTMC, connective tissue-type mast cell; eNOS, endothelial nitric oxide synthase; ERα, estrogen receptor α; IFNγ, interferon-γ; iNOS, inducible nitric oxide synthase; MHC, major histocompatibility complex; MMC, mucosal type mast cell; MMCP, mouse mast cell protease; nNOS, neuronal nitric oxide synthase; NOS, nitric oxide synthase; PBMC, human peripheral blood-derived mast cell; PCMC, peritoneal cell-derived mast cell; PMC, peritoneal mast cell; PR, progesterone receptor; RBL-2H3, rat basophilic leukemia 2H3 cell line; SCF, stem cell factor; SMC, human skin-derived mast cell; TGFβ1, transforming growth factor-β1.
  2. aUnpublished data (see text for details).
PowerPoint slide